OR WAIT null SECS
Emergence of advanced manufacturing technology to ensure quality of biopharmaceutical drugs combined with efforts to identify a regulatory pathway indicate that a distributed manufacturing model is within reach.
There is no such thing as a perfect linker.
A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.
Re-evaluating the basics of mAb production may be beneficial for the biopharma industry as a whole.
USP offers strategies to minimize residual impurities in downstream processing.
November 02, 2023
Hollie Barton, senior director, Chromatographic Services, for the PPD clinical research business of Thermo Fisher Scientific, discusses ways that labs are addressing the pressure of rapid analytical turnaround times.
The new centralized hub will provide advanced testing of nucleic acids, which is expected to simplify mRNA substance testing.
As part of a $30 million investment, Aragen is setting up a new biologics manufacturing facility in Bangalore, India.
November 01, 2023
The implementation of Industry 4.0 is projected to save time and cost for designing an optimal manufacturing process.
Interest grows in AI, digitalization, robotics, and sustainability.
Sara Fathollahi, PhD, product application specialist at DFE Pharma, makes the case of how excipient suppliers can support the transition from batch to continuous manufacturing.
Sara Fathollahi, PhD, product application specialist at DFE Pharma, discusses a major challenge in the adoption of continuous manufacturing.